Related Experiment Video
Updated: Jan 15, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Emerging Nanonutraceuticals against Obesity
Linjie Ni1, Minmin Peng1, Yiying Liang1,2
1State Key Laboratory of Vaccines for Infectious Diseases Xiang An Biomedicine Laboratory Xiang'an Hospital of Xiamen University National Innovation Platform for Industry-Education Integration in Vaccine Research School of Public Health Xiamen University Xiamen 361102 China.
Abstract:
Obesity, a global public health issue, often emanates from dietary imbalances. Strategic nutraceutical supplementation can fundamentally mitigate or even reverse obesity with minimal adverse effects. Nonetheless, most antiobesity nutraceuticals possess intrinsic limitations in oral administration, such as low solubility, chemical instability, and susceptibility to biodegradation. These drastically diminish their bioavailability, thereby restricting their effectiveness in combating obesity. The emergence of nanotechnology heralds a transformative paradigm to clear this hurdle. A myriad of nutraceuticals has been nanomodified for obesity management, yet a comprehensive compilation on this topic is currently absent. Accordingly, this review focuses on all antiobesity nanonutraceuticals and expounds their characteristics, enhanced bioavailability, and weight-loss mechanisms according to six primary categories: carbohydrates, lipids, proteins, vitamins, minerals, and phytochemicals. Their application perspectives, impediments, and potential solutions are further discussed. As a pivotal reference, this review will accelerate the in-depth development of nanonutraceuticals and their translation from bench to bedside in the ongoing battle against the global obesity epidemic.
More Related Videos
13:09Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet
Published on: July 31, 2021
08:53Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
Published on: April 16, 2019
Related Concept Videos
Obesity
Regulation of Food Intake
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion